New entrants to this market could drive prices down, but I worry that if a few companies continue to represent virtually all of the market, they will maintain their price discipline and the costs of these medications will leave them out of reach for many who could benefit from them
La L-carnitine joue un rle dans lutilisation des graisses comme source dnergie
But in the beginning of last year, we, we said, no, it has to be for a diabetes prescription. -Senior Human Resources Leader, large services organization The use of GLP-1 agonists was higher than expected for many large employers including for over half (59%) of employers over 5,000 workers Since then, many larger employers covering GLP-1 agonists for weight loss reported higher than expected use of the medications and significant impacts on their prescription spending
Cherney DZ, Dekkers CC, Barbour SJ, Cattran D, Abdul Gafor AH, Greasley PJ, et al